841 related articles for article (PubMed ID: 32333488)
1. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
2. The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's disease.
Huang J; Tao Q; Ang TFA; Farrell J; Zhu C; Wang Y; Stein TD; Lunetta KL; Massaro J; Mez J; Au R; Farrer LA; Qiu WQ; Zhang X;
Transl Psychiatry; 2022 Dec; 12(1):523. PubMed ID: 36550123
[TBL] [Abstract][Full Text] [Related]
3. Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations.
Mao YF; Guo ZY; Pu JL; Chen YX; Zhang BR
Neurosci Lett; 2015 Nov; 609():235-9. PubMed ID: 26455864
[TBL] [Abstract][Full Text] [Related]
4. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease.
Heidari F; Ansstas G; Ajamian F
Gerontology; 2022; 68(4):421-430. PubMed ID: 34569532
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
6. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
[TBL] [Abstract][Full Text] [Related]
7. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
[TBL] [Abstract][Full Text] [Related]
8. Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.
Ebbert MTW; Boehme KL; Wadsworth ME; Staley LA; ; ; Mukherjee S; Crane PK; Ridge PG; Kauwe JSK
Alzheimers Dement; 2016 Feb; 12(2):121-129. PubMed ID: 26449541
[TBL] [Abstract][Full Text] [Related]
9. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
10. Multiple Sclerosis: Shall We Target CD33?
Siokas V; Tsouris Z; Aloizou AM; Bakirtzis C; Liampas I; Koutsis G; Anagnostouli M; Bogdanos DP; Grigoriadis N; Hadjigeorgiou GM; Dardiotis E
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198164
[TBL] [Abstract][Full Text] [Related]
11. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
[TBL] [Abstract][Full Text] [Related]
12. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
[TBL] [Abstract][Full Text] [Related]
13. Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.
Rezazadeh M; Khorrami A; Yeghaneh T; Talebi M; Kiani SJ; Heshmati Y; Gharesouran J
Neuromolecular Med; 2016 Mar; 18(1):37-49. PubMed ID: 26553058
[TBL] [Abstract][Full Text] [Related]
14. Effect of APOE and CD33 on Cognitive Decline.
Hayden KM; Lutz MW; Kuchibhatla M; Germain C; Plassman BL
PLoS One; 2015; 10(6):e0130419. PubMed ID: 26102276
[TBL] [Abstract][Full Text] [Related]
15. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
16. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.
Walker DG; Whetzel AM; Serrano G; Sue LI; Beach TG; Lue LF
Neurobiol Aging; 2015 Feb; 36(2):571-82. PubMed ID: 25448602
[TBL] [Abstract][Full Text] [Related]
17. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S
Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585
[TBL] [Abstract][Full Text] [Related]
18. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
[TBL] [Abstract][Full Text] [Related]
19. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
[TBL] [Abstract][Full Text] [Related]
20. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
